	Effects of Technology-Based Perturbation Training During Walking on Physical Function in Stroke, Multiple Sclerosis, and Parkinson's Disease: A Scoping Review. NeuroRehabilitation Lahtio H, Kulmala R, Saastamoinen L, Suikkanen S, Rintala A. PMID: 42390369 [PubMed - as supplied by publisher]
	Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis. bioRxiv Mounts K, Liu Y, Fujita M, Oyegunle J, Neziraj T, Pollak SV, Nandakumar R, Ngouth N, Steele SU, Cortese I, White CC, Jacobson S, Reich DS, De Jager PL. PMID: 42388799 [PubMed]
	Beyond dissemination criteria: lesion-based longitudinal MRI of atypical demyelinating lesions at the boundary of multiple sclerosis. J Neurol Aratake Y, Yoshinaga K, Ashida S, Fujii C, Hamatani M, Kimura K, Ochi H, Takahashi R, Kondo T. PMID: 42387037 [PubMed - indexed for MEDLINE]
	Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study. J Neurol Neurosurg Psychiatry Maunula A, Laakso SM, Viitala M, Sumelahti ML, Atula S. PMID: 42386505 [PubMed - as supplied by publisher]
	Discontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control study. Mult Scler Relat Disord Cabañas Engenios G, Mena García N, Garay Albízuri P, Llanes Ferrer A, Sánchez Asensio A, Romero Ferro J, Gil Martinez L, Campos Jiménez M, Pastor González R, Rodríguez Jorge F, Sainz De La Maza S, Monreal Laguillo E, Villar LM, Masjuan Vallejo J, Costa-Frossard L, Chico García JL. PMID: 42385519 [PubMed - as supplied by publisher]
	Advances in Multiple Sclerosis. N Engl J Med Hauser SL. PMID: 42384871 [PubMed - indexed for MEDLINE]
	Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis. N Engl J Med Torkildsen Ø, Brustad HK, Høgestøl EA, Alstadhaug KB, Bhan A, Flemmen HØ, Habbestad A, Høglund RAA, LeBlanc M, Lopen P, Lorentzen ÅR, Morsund ÅH, Lossius A, Lundby R, Nygaard GO, Rød BE, Simonsen CS, Steffensen L, Torgauten H, Piehl F, Wergeland S, Myhr KM, OVERLORD-MS Investigators. PMID: 42384870 [PubMed - indexed for MEDLINE]
	Exploring attitudes and acceptance of artificial intelligence in multiple sclerosis from the patient perspective. PLOS Digit Health Inojosa H, Masanneck L, Voigt I, Schriefer D, von Horsten N, Wenk J, Gasparovic-Curtini I, Haase R, Meuth SG, Huttner HB, Gilbert S, Pawlitzki M, Ziemssen T. PMID: 42384671 [PubMed]
	T Helper Cells and Cytokine Networks in the Immunopathogenesis of Multiple Sclerosis. Immunotargets Ther Egba SI, Ikechukwu GC, Okereke CI, Orhonigbe IO, Uroko RI, Ugwu OPC. PMID: 42383100 [PubMed]
	Multiple sclerosis patients under treatment with interferon Î²1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine. Front Immunol Liotti A, Maniscalco GT, Ferrara AL, Mazzone V, Dehbozorgi M, Szabó A, Belardo M, Marcogiuseppe D, De Martino A, Di Battista ME, Servillo G, Moreggia O, Di Giulio Cesare D, Andreone V, Varricchi G, De Rosa V. PMID: 42382741 [PubMed - indexed for MEDLINE]
	Unlocking the healing power of Berberine: A promising aid for multiple sclerosis. IBRO Neurosci Rep Chahardehi AM, Karimi Khordeh N, Limoudehi NM, Dasoomi H, Omrani R, Nikjoo M, Mamaghani EM, Nasiri R, Meigoli MSS, Shoja F, Jafari-Ardakan Z, Arefnezhad R, Rezaei-Tazangi F. PMID: 42381886 [PubMed]
	Distinct immunological signatures in autoimmunity: a multi-plex analysis for the differential diagnosis of established and undifferentiated autoimmune diseases (a cross-sectional pilot study). Rheumatol Int Toliopoulos IK, Bougiouklis D, Papagiannakis P, Stavridis C. PMID: 42377505 [PubMed - indexed for MEDLINE]
	Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2â€‰years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab. Mult Scler MacMillan EL, Russell-Schulz B, Alejo G, Harp C, Cameron B, Winger R, Jia S, Herman A, Kassam J, Waine M, Vavasour IM, Cross H, Tam R, Traboulsee AL, Carruthers R, Kolind SH. PMID: 42376811 [PubMed - as supplied by publisher]
	Intrathecal synthesis of antiviral IgG antibodies in multiple sclerosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Licha K, Kusnierova P, Revendova KZ, Thon V, Zeman D. PMID: 42374901 [PubMed - as supplied by publisher]
	Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study. J Neurol Bove R, Langdon D, Maciejowski M, Jasi, Dufek M, Abeyewickreme A, Rauh A, Fu H, Khan IA, Böhringer M, Eichau SM, Derfuss T. PMID: 42371147 [PubMed - indexed for MEDLINE]
	Effects of transcranial direct current stimulation in multiple sclerosis: Recent findings of clinical studies and animal models. Acta Neurobiol Exp (Wars) Hashemi M, Tajik MH, Javanbakht P, Taghizadeh F, Zarini D, Mojaverrostami S. PMID: 42370615 [PubMed - indexed for MEDLINE]
	Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial. Health Technol Assess Williams T, Blackstone J, John N, Braisher M, De Angelis F, Bianchi A, Calvi A, Doshi A, Mangion SA, Wade C, Bordea E, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson NP, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri SK, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Tebbs S, Hawton A, Hunter R, Giovannoni G, Ciccarelli O, Beveridge J, Nixon S, Thompson AJ, Greenwood J, Pearson O, Evangelou N, Sharrack B, Galea I, Pavitt S, Chandran S, Ford HL, Nicholas JM, Chataway J, MS-STAT2 Investigators. PMID: 42370465 [PubMed - indexed for MEDLINE]
	Correlation Is Not Prediction: Reassessing Predictive MRI Evidence in Guidelines for Persons With Relapsing-Remitting Multiple Sclerosis. J Cent Nerv Syst Dis Minas D, Buchka S, Havla J, Mansmann U. PMID: 42369642 [PubMed]
	The effect of a web-based self-care education programme on the health-promoting behaviours of patients with multiple sclerosis: a randomised controlled trial. J Res Nurs Akbari S, Amini K, Gheiasi SF, Hanifi N. PMID: 42368038 [PubMed - as supplied by publisher]
	Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis. Front Immunol Oreja-Guevara C, Meuth SG, Grigoriadis N, Vermersch P, Hartung HP, Sörensen PS, Leocani L, Schmierer K, Gold R, Fernández Ó. PMID: 42367807 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 44379

Page 1 of 2219



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy